155 related articles for article (PubMed ID: 22866145)
1. Management of neuroendocrine carcinomas of the breast: A rare entity.
Yildirim Y; Elagoz S; Koyuncu A; Aydin C; Karadayi K
Oncol Lett; 2011 Sep; 2(5):887-890. PubMed ID: 22866145
[TBL] [Abstract][Full Text] [Related]
2. Primary neuroendocrine carcinoma of the breast A single Center experience and review of the literature.
Locurto P; Antona AD; Grillo A; Ciulla A; Martorana S; Cipolla C; Graceffa G; Vieni S
Ann Ital Chir; 2016 Nov; 87():. PubMed ID: 27905324
[TBL] [Abstract][Full Text] [Related]
3. Primary neuroendocrine carcinoma breast: our experience.
Suhani ; Ali S; Desai G; Thomas S; Aggarwal L; Meena K; Kumar J; Jain M; Tudu SK
Breast Dis; 2014; 34(3):95-9. PubMed ID: 24004513
[TBL] [Abstract][Full Text] [Related]
4. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
5. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Jian JJ; Cheng SH; Tsai SY; Leu SY; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):980-8. PubMed ID: 11958892
[TBL] [Abstract][Full Text] [Related]
6. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
7. Primary Large-Cell Neuroendocrine Carcinoma of the Breast Occurring in a Pre-Menopausal Woman.
Yoshimura N; Sasada T; Yonehara S
Breast Care (Basel); 2015 Aug; 10(4):281-3. PubMed ID: 26600766
[TBL] [Abstract][Full Text] [Related]
8. Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast.
von Minckwitz G; Sinn HP; Raab G; Loibl S; Blohmer JU; Eidtmann H; Hilfrich J; Merkle E; Jackisch C; Costa SD; Caputo A; Kaufmann M;
Breast Cancer Res; 2008; 10(2):R30. PubMed ID: 18380893
[TBL] [Abstract][Full Text] [Related]
9. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
Ding HY; Gao LX
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiated carcinomas of the breast: a distinct entity.
Zekioglu O; Erhan Y; Ciriş M; Bayramoglu H
Breast; 2003 Aug; 12(4):251-7. PubMed ID: 14659309
[TBL] [Abstract][Full Text] [Related]
12. Primary neuroendocrine tumors of the breast: two case reports and review of the literature.
Hejjane L; Oualla K; Bouchbika Z; Bourhafour M; Lhlou Mimi A; Boubacar E; Benider A; Benbrahim Z; Aarifi S; Mellas N
J Med Case Rep; 2020 Mar; 14(1):41. PubMed ID: 32156307
[TBL] [Abstract][Full Text] [Related]
13. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
14. Primary neuroendocrine carcinoma of breast: a rare case report.
Murthy V; Geethamala K; Kumar B; Sudharao M
Ann Med Health Sci Res; 2013 Nov; 3(Suppl 1):S35-7. PubMed ID: 24349846
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
16. [Asynchronous Bilateral Neuroendocrine Breast Carcinoma - A Case Report].
Abe K; Mori S; Koyama Y; Takagi M; Adachi K; Hara Y; Waga E; Enomoto K; Tomita R; Fujisaki S; Hirano T; Sakurai K
Gan To Kagaku Ryoho; 2018 Apr; 45(4):682-684. PubMed ID: 29650834
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
18. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients.
Shin SJ; DeLellis RA; Ying L; Rosen PP
Am J Surg Pathol; 2000 Sep; 24(9):1231-8. PubMed ID: 10976697
[TBL] [Abstract][Full Text] [Related]
19. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
20. The role of axillary dissection in mammographically detected carcinoma.
Pandelidis SM; Peters KL; Walusimbi MS; Casady RL; Laux SV; Cavanaugh SH; Bauer TL
J Am Coll Surg; 1997 Apr; 184(4):341-5. PubMed ID: 9100677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
